Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Treatment and Prognosis of Primary Hepatobiliary Cancer: A Cohort Study in Central China

NCT05520801 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05520801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Treatment and Prognosis of Primary Hepatobiliary Cancer: A Cohort Study in Central China
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2020
Completion date
March 31, 2025
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms, hepatocellular carcinoma